InvestorsHub Logo
Followers 47
Posts 3929
Boards Moderated 0
Alias Born 03/04/2012

Re: Justfactsmam post# 290257

Thursday, 04/02/2020 8:31:16 PM

Thursday, April 02, 2020 8:31:16 PM

Post# of 402831
With three different successful phase 2 trials with Brilacidin, and now indications of efficacy against C-19, how does one value such a scenario with all the promising B indications?

Competitor cytodyn has about twice the number of shares and still maintains a 1 billion market cap after getting hammered down today.



Better yet...be acquired at the right price.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News